Agenus | AGEN - Уставный капитал обыкновенных акций





Уставный капитал обыкновенных акций Изменить Дата
AbbVie USD 1.77B 608K 2026-06
Agenus USD 38.52M 3.2M 2026-03
Amgen USD 541M 0 2026-09
AstraZeneca USD 1.55B 28K 2026-09
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Celldex Therapeutics USD 78.53M 34K 2026-09
CSL USD 482.13M 93.87M 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Glaxosmithkline GBP 2.02B 2.03B 2026-09
Incyte USD 200.98M 1.03M 2026-06
Intrexon USD 0 0 2024-06
J&J USD 2.41B 1.64M 2026-06
Jiangsu Hengrui CNY 6.64B 0 2026-09
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
MacroGenics USD 63.65M 86K 2026-06
Merck EUR 434.78M 0 2026-06
Merck USD 2.47B 1.05M 2026-06
Northwest Biotherapeutics USD 1.61B 88.6M 2026-03
Novartis USD 1.89B 12.09M 2026-09
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.7B 0 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Rigel Pharmaceuticals USD 17K 158K 2024-06
Veracyte USD 80.39M 598K 2026-09